Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高级检索
  • Clinical outcomes with mepoliz...
  • 引用
  • 发送短信
  • 推荐此
  • 打印
  • 导出纪录
    • 导出到 RefWorks
    • 导出到 EndNoteWeb
    • 导出到 EndNote
  • Permanent link
导出完成 — 
Clinical outcomes with mepolizumab therapy in routine practice in the oxford cohort

Clinical outcomes with mepolizumab therapy in routine practice in the oxford cohort

书目详细资料
Main Authors: Gittins, A, Borg, C, Connolly, C, Hynes, G, Shrimanker, R, Thulborn, S, Gould, N, Cane, J, Pavord, I, Hinks, T
格式: Conference item
出版: BMJ Publishing Group 2018
  • 持有资料
  • 实物特征
  • 相似书籍
  • 职员浏览

相似书籍

  • Identifying bacterial airways infection in stable severe asthma using Oxford nanopore sequencing technologies
    由: Jabeen, MF, et al.
    出版: (2022)
  • Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
    由: Moran, A, et al.
    出版: (2020)
  • Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
    由: Moran, AM, et al.
    出版: (2020)
  • Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
    由: Howell, I, et al.
    出版: (2024)
  • Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
    由: Hynes, G, et al.
    出版: (2017)

检索选项

  • 检索历史
  • 高级检索

查找更多

  • 浏览目录
  • 按字母顺序浏览
  • 探索频道
  • 课程储备
  • 新项目

需要帮助?

  • 检索技巧
  • 咨询台
  • 常见问题